Teva (TEVA) Could Recall a Batch of Treanda -WSJ
Get Alerts TEVA Hot Sheet
Price: $14.11 -2.22%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: +1.6%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: +1.6%
Join SI Premium – FREE
Teva (Nasdaq: TEVA) shares have pushed to session lows as WSJ is reporting Teva (Nasdaq: TEVA) may recall a batch of treanda.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VIZIO Holding Corp. (VZIO) on Watch Following Cautious M&A Chatter
- Liberty Media in Exclusive Talks to Buy Dorna Sports For EUR 4B - FT
- Bristol-Myers Squibb (BMY) Announces KRYSTAL-12 Trial of KRAZATI Met Primary Endpoint
Create E-mail Alert Related Categories
FDA, RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!